Back to SYRE
Venrock Adviser, LLC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$221.3M
Q3 2026
Peak value
$265M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $120.7M |
| Q1 2026 | $185.9M |
| Q2 2026 | $265M |
| Q3 2026 | $221.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $221.3M | 2.49M | — | — |
| Q2 2026 | $265M | 2.99M | — | — |
| Q1 2026 | $185.9M | 3.69M | — | — |
| Q4 2025 | $120.7M | 3.69M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M